GlassScriptPhysician profile
Elizabeth Abrams
NPI 1104956697
$1,365.73
in general payments reported to CMS, 2019-2025
9 companies · $483 in 2025
The $483 reported for 2025 was more than what 90% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2021: $50.09 · 2022: $211 · 2023: $416 · 2024: $19.23 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495 · Gift: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.92 |
| Gift | $422.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $422.97 | 2025 | Opalescence |
| Nobel Biocare USA | $415.90 | 2023 | Nobelactive |
| Implant Direct Sybron International LLC | $156.00 | 2019-2022 | |
| Zimvie INC. | $117.04 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $100.00 | 2019 | |
| Straumann USA LLC | $52.73 | 2024-2025 | |
| Kerr Corporation | $51.00 | 2019 | |
| Premier Dental Products Company | $35.00 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $15.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Abrams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.